Silencing the AGPAT‐4 gene using siRNA in PHT, (n = 5) resulted in ~40% decrease in AGPAT‐4 protein expression (Figure 3, paired t‐est p = 0.04). The gene discussed is AGPAT4; the disease is pulmonary hypertension, primary, 1.